▶ 調査レポート

製薬・セチリジンOTCの世界市場レポート2020

• 英文タイトル:Global Pharma and Cetirizine OTC Sales Market Report 2020

が調査・発行した産業分析レポートです。製薬・セチリジンOTCの世界市場レポート2020 / Global Pharma and Cetirizine OTC Sales Market Report 2020 / MRC2102QY10620資料のイメージです。• レポートコード:MRC2102QY10620
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、148ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の製薬・セチリジンOTC市場について種類別(タブレット、カプセル)、用途別(病院、診療所、ドラッグストア、その他)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・製薬・セチリジンOTC市場の概要
・世界の主要地域別製薬・セチリジンOTC市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の製薬・セチリジンOTC市場規模2015-2026:種類別(タブレット、カプセル)
・世界の製薬・セチリジンOTC市場規模2015-2026:用途別(病院、診療所、ドラッグストア、その他)
・製薬・セチリジンOTCの米国市場規模2015-2020
・製薬・セチリジンOTCのヨーロッパ市場規模2015-2020
・製薬・セチリジンOTCの中国市場規模2015-2020
・製薬・セチリジンOTCの日本市場規模2015-2020
・製薬・セチリジンOTCの東南アジア市場規模2015-2020
・製薬・セチリジンOTCのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・製薬・セチリジンOTCの製造コスト分析
・販売チャネル、流通業者、顧客
・製薬・セチリジンOTCの市場動向・機会・課題
・調査の結論

Cetirizine Hydrochloride (trade names Zirtec, Zyrtec, Reactine) is a second-generation antihistamine used in the treatment of hay fever, allergies, angioedema, and urticaria.[1] It is a major metabolite of hydroxyzine, and a racemic selective H1 receptor antagonist.

Market Analysis and Insights: Global Pharma and Cetirizine OTC Market
The global Pharma and Cetirizine OTC market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Pharma and Cetirizine OTC Scope and Market Size
The global Pharma and Cetirizine OTC market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharma and Cetirizine OTC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Pharma and Cetirizine OTC market is segmented into
Tablet
Capsule

Segment by Application, the Pharma and Cetirizine OTC market is segmented into
Hospital
Clinic
Drug Store
Other

The Pharma and Cetirizine OTC market is analysed and market size information is provided by regions (countries). Segment by Application, the Pharma and Cetirizine OTC market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Pharma and Cetirizine OTC Market Share Analysis
Pharma and Cetirizine OTC market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pharma and Cetirizine OTC business, the date to enter into the Pharma and Cetirizine OTC market, Pharma and Cetirizine OTC product introduction, recent developments, etc.

The major vendors covered:
J & J
Sanofi
Pl Developments
APOTEX
Teva
Mckesson
Perrigo
Perrigo
CVS Pharmacy
Major® Pharmaceuticals
Mylan
Amneal
Novartis
Cardinal
Jubilant Life Sciences
Novel Laboratories
Medline
Macleods
Torrent Pharmaceuticals
Micro Labs
Dr. Reddy’s
Cipla
Aurobindo Pharma
Glenmark
Synthon
Magno-Humphries
Unique Pharmaceutical
Allegiant Health
Silarx Pharmaceuticals
Sun Pharma

レポート目次

1 Pharma and Cetirizine OTC Market Overview
1.1 Pharma and Cetirizine OTC Product Scope
1.2 Pharma and Cetirizine OTC Segment by Type
1.2.1 Global Pharma and Cetirizine OTC Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Pharma and Cetirizine OTC Segment by Application
1.3.1 Global Pharma and Cetirizine OTC Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.3.5 Other
1.4 Pharma and Cetirizine OTC Market Estimates and Forecasts (2015-2026)
1.4.1 Global Pharma and Cetirizine OTC Sales Growth Rate (2015-2026)
1.4.2 Global Pharma and Cetirizine OTC Revenue and Growth Rate (2015-2026)
1.4.3 Global Pharma and Cetirizine OTC Price Trends (2015-2026)

2 Pharma and Cetirizine OTC Estimate and Forecast by Region
2.1 Global Pharma and Cetirizine OTC Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Pharma and Cetirizine OTC Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Pharma and Cetirizine OTC Sales Market Share by Region (2015-2020)
2.2.2 Global Pharma and Cetirizine OTC Revenue Market Share by Region (2015-2020)
2.3 Global Pharma and Cetirizine OTC Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Pharma and Cetirizine OTC Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Pharma and Cetirizine OTC Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
2.4.2 Europe Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
2.4.3 China Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
2.4.4 Japan Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
2.4.6 India Pharma and Cetirizine OTC Estimates and Projections (2015-2026)
3 Global Pharma and Cetirizine OTC Competition Landscape by Players
3.1 Global Top Pharma and Cetirizine OTC Players by Sales (2015-2020)
3.2 Global Top Pharma and Cetirizine OTC Players by Revenue (2015-2020)
3.3 Global Pharma and Cetirizine OTC Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Cetirizine OTC as of 2019)
3.4 Global Pharma and Cetirizine OTC Average Price by Company (2015-2020)
3.5 Manufacturers Pharma and Cetirizine OTC Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Pharma and Cetirizine OTC Players (Opinion Leaders)
4 Global Pharma and Cetirizine OTC Market Size by Type
4.1 Global Pharma and Cetirizine OTC Historic Market Review by Type (2015-2020)
4.1.1 Global Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
4.1.2 Global Pharma and Cetirizine OTC Revenue Market Share by Type (2015-2020)
4.1.3 Global Pharma and Cetirizine OTC Price by Type (2015-2020)
4.2 Global Pharma and Cetirizine OTC Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Pharma and Cetirizine OTC Sales Forecast by Type (2021-2026)
4.2.2 Global Pharma and Cetirizine OTC Revenue Forecast by Type (2021-2026)
4.2.3 Global Pharma and Cetirizine OTC Price Forecast by Type (2021-2026)
5 Global Pharma and Cetirizine OTC Market Size by Application
5.1 Global Pharma and Cetirizine OTC Historic Market Review by Application (2015-2020)
5.1.1 Global Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
5.1.2 Global Pharma and Cetirizine OTC Revenue Market Share by Application (2015-2020)
5.1.3 Global Pharma and Cetirizine OTC Price by Application (2015-2020)
5.2 Global Pharma and Cetirizine OTC Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Pharma and Cetirizine OTC Sales Forecast by Application (2021-2026)
5.2.2 Global Pharma and Cetirizine OTC Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharma and Cetirizine OTC Price Forecast by Application (2021-2026)

6 United States Pharma and Cetirizine OTC Market Facts & Figures
6.1 United States Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
6.2 United States Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
6.3 United States Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

7 Europe Pharma and Cetirizine OTC Market Facts & Figures
7.1 Europe Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
7.2 Europe Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
7.3 Europe Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

8 China Pharma and Cetirizine OTC Market Facts & Figures
8.1 China Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
8.2 China Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
8.3 China Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

9 Japan Pharma and Cetirizine OTC Market Facts & Figures
9.1 Japan Pharma and Cetirizine OTC Sales Market Share by Company (3015-3030)
9.2 Japan Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
9.3 Japan Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

10 Southeast Asia Pharma and Cetirizine OTC Market Facts & Figures
10.1 Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

11 India Pharma and Cetirizine OTC Market Facts & Figures
11.1 India Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
11.2 India Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
11.3 India Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Pharma and Cetirizine OTC Business
12.1 J & J
12.1.1 J & J Corporation Information
12.1.2 J & J Business Overview
12.1.3 J & J Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 J & J Pharma and Cetirizine OTC Products Offered
12.1.5 J & J Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pharma and Cetirizine OTC Products Offered
12.2.5 Sanofi Recent Development
12.3 Pl Developments
12.3.1 Pl Developments Corporation Information
12.3.2 Pl Developments Business Overview
12.3.3 Pl Developments Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pl Developments Pharma and Cetirizine OTC Products Offered
12.3.5 Pl Developments Recent Development
12.4 APOTEX
12.4.1 APOTEX Corporation Information
12.4.2 APOTEX Business Overview
12.4.3 APOTEX Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.4.4 APOTEX Pharma and Cetirizine OTC Products Offered
12.4.5 APOTEX Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Pharma and Cetirizine OTC Products Offered
12.5.5 Teva Recent Development
12.6 Mckesson
12.6.1 Mckesson Corporation Information
12.6.2 Mckesson Business Overview
12.6.3 Mckesson Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mckesson Pharma and Cetirizine OTC Products Offered
12.6.5 Mckesson Recent Development
12.7 Perrigo
12.7.1 Perrigo Corporation Information
12.7.2 Perrigo Business Overview
12.7.3 Perrigo Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Perrigo Pharma and Cetirizine OTC Products Offered
12.7.5 Perrigo Recent Development
12.8 Perrigo
12.8.1 Perrigo Corporation Information
12.8.2 Perrigo Business Overview
12.8.3 Perrigo Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Perrigo Pharma and Cetirizine OTC Products Offered
12.8.5 Perrigo Recent Development
12.9 CVS Pharmacy
12.9.1 CVS Pharmacy Corporation Information
12.9.2 CVS Pharmacy Business Overview
12.9.3 CVS Pharmacy Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.9.4 CVS Pharmacy Pharma and Cetirizine OTC Products Offered
12.9.5 CVS Pharmacy Recent Development
12.10 Major® Pharmaceuticals
12.10.1 Major® Pharmaceuticals Corporation Information
12.10.2 Major® Pharmaceuticals Business Overview
12.10.3 Major® Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Major® Pharmaceuticals Pharma and Cetirizine OTC Products Offered
12.10.5 Major® Pharmaceuticals Recent Development
12.11 Mylan
12.11.1 Mylan Corporation Information
12.11.2 Mylan Business Overview
12.11.3 Mylan Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Mylan Pharma and Cetirizine OTC Products Offered
12.11.5 Mylan Recent Development
12.12 Amneal
12.12.1 Amneal Corporation Information
12.12.2 Amneal Business Overview
12.12.3 Amneal Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Amneal Pharma and Cetirizine OTC Products Offered
12.12.5 Amneal Recent Development
12.13 Novartis
12.13.1 Novartis Corporation Information
12.13.2 Novartis Business Overview
12.13.3 Novartis Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Novartis Pharma and Cetirizine OTC Products Offered
12.13.5 Novartis Recent Development
12.14 Cardinal
12.14.1 Cardinal Corporation Information
12.14.2 Cardinal Business Overview
12.14.3 Cardinal Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Cardinal Pharma and Cetirizine OTC Products Offered
12.14.5 Cardinal Recent Development
12.15 Jubilant Life Sciences
12.15.1 Jubilant Life Sciences Corporation Information
12.15.2 Jubilant Life Sciences Business Overview
12.15.3 Jubilant Life Sciences Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Jubilant Life Sciences Pharma and Cetirizine OTC Products Offered
12.15.5 Jubilant Life Sciences Recent Development
12.16 Novel Laboratories
12.16.1 Novel Laboratories Corporation Information
12.16.2 Novel Laboratories Business Overview
12.16.3 Novel Laboratories Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novel Laboratories Pharma and Cetirizine OTC Products Offered
12.16.5 Novel Laboratories Recent Development
12.17 Medline
12.17.1 Medline Corporation Information
12.17.2 Medline Business Overview
12.17.3 Medline Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Medline Pharma and Cetirizine OTC Products Offered
12.17.5 Medline Recent Development
12.18 Macleods
12.18.1 Macleods Corporation Information
12.18.2 Macleods Business Overview
12.18.3 Macleods Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Macleods Pharma and Cetirizine OTC Products Offered
12.18.5 Macleods Recent Development
12.19 Torrent Pharmaceuticals
12.19.1 Torrent Pharmaceuticals Corporation Information
12.19.2 Torrent Pharmaceuticals Business Overview
12.19.3 Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Torrent Pharmaceuticals Pharma and Cetirizine OTC Products Offered
12.19.5 Torrent Pharmaceuticals Recent Development
12.20 Micro Labs
12.20.1 Micro Labs Corporation Information
12.20.2 Micro Labs Business Overview
12.20.3 Micro Labs Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Micro Labs Pharma and Cetirizine OTC Products Offered
12.20.5 Micro Labs Recent Development
12.21 Dr. Reddy’s
12.21.1 Dr. Reddy’s Corporation Information
12.21.2 Dr. Reddy’s Business Overview
12.21.3 Dr. Reddy’s Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Dr. Reddy’s Pharma and Cetirizine OTC Products Offered
12.21.5 Dr. Reddy’s Recent Development
12.22 Cipla
12.22.1 Cipla Corporation Information
12.22.2 Cipla Business Overview
12.22.3 Cipla Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Cipla Pharma and Cetirizine OTC Products Offered
12.22.5 Cipla Recent Development
12.23 Aurobindo Pharma
12.23.1 Aurobindo Pharma Corporation Information
12.23.2 Aurobindo Pharma Business Overview
12.23.3 Aurobindo Pharma Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Aurobindo Pharma Pharma and Cetirizine OTC Products Offered
12.23.5 Aurobindo Pharma Recent Development
12.24 Glenmark
12.24.1 Glenmark Corporation Information
12.24.2 Glenmark Business Overview
12.24.3 Glenmark Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Glenmark Pharma and Cetirizine OTC Products Offered
12.24.5 Glenmark Recent Development
12.25 Synthon
12.25.1 Synthon Corporation Information
12.25.2 Synthon Business Overview
12.25.3 Synthon Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.25.4 Synthon Pharma and Cetirizine OTC Products Offered
12.25.5 Synthon Recent Development
12.26 Magno-Humphries
12.26.1 Magno-Humphries Corporation Information
12.26.2 Magno-Humphries Business Overview
12.26.3 Magno-Humphries Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.26.4 Magno-Humphries Pharma and Cetirizine OTC Products Offered
12.26.5 Magno-Humphries Recent Development
12.27 Unique Pharmaceutical
12.27.1 Unique Pharmaceutical Corporation Information
12.27.2 Unique Pharmaceutical Business Overview
12.27.3 Unique Pharmaceutical Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.27.4 Unique Pharmaceutical Pharma and Cetirizine OTC Products Offered
12.27.5 Unique Pharmaceutical Recent Development
12.28 Allegiant Health
12.28.1 Allegiant Health Corporation Information
12.28.2 Allegiant Health Business Overview
12.28.3 Allegiant Health Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.28.4 Allegiant Health Pharma and Cetirizine OTC Products Offered
12.28.5 Allegiant Health Recent Development
12.29 Silarx Pharmaceuticals
12.29.1 Silarx Pharmaceuticals Corporation Information
12.29.2 Silarx Pharmaceuticals Business Overview
12.29.3 Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.29.4 Silarx Pharmaceuticals Pharma and Cetirizine OTC Products Offered
12.29.5 Silarx Pharmaceuticals Recent Development
12.30 Sun Pharma
12.30.1 Sun Pharma Corporation Information
12.30.2 Sun Pharma Business Overview
12.30.3 Sun Pharma Pharma and Cetirizine OTC Sales, Revenue and Gross Margin (2015-2020)
12.30.4 Sun Pharma Pharma and Cetirizine OTC Products Offered
12.30.5 Sun Pharma Recent Development

13 Pharma and Cetirizine OTC Manufacturing Cost Analysis
13.1 Pharma and Cetirizine OTC Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Pharma and Cetirizine OTC
13.4 Pharma and Cetirizine OTC Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Pharma and Cetirizine OTC Distributors List
14.3 Pharma and Cetirizine OTC Customers

15 Market Dynamics
15.1 Pharma and Cetirizine OTC Market Trends
15.2 Pharma and Cetirizine OTC Opportunities and Drivers
15.3 Pharma and Cetirizine OTC Market Challenges
15.4 Pharma and Cetirizine OTC Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Pharma and Cetirizine OTC Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Pharma and Cetirizine OTC Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Pharma and Cetirizine OTC Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Pharma and Cetirizine OTC Sales (K Units) by Region (2015-2020)
Table 5. Global Pharma and Cetirizine OTC Sales Market Share by Region (2015-2020)
Table 6. Global Pharma and Cetirizine OTC Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Pharma and Cetirizine OTC Revenue Share by Region (2015-2020)
Table 8. Global Pharma and Cetirizine OTC Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Pharma and Cetirizine OTC Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Pharma and Cetirizine OTC Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Pharma and Cetirizine OTC Revenue Share Forecast by Region (2021-2026)
Table 12. Global Pharma and Cetirizine OTC (K Units) of Key Companies (2015-2020)
Table 13. Global Pharma and Cetirizine OTC Sales Share by Company (2015-2020)
Table 14. Global Pharma and Cetirizine OTC Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Pharma and Cetirizine OTC Revenue Share by Company (2015-2020)
Table 16. Global Pharma and Cetirizine OTC by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharma and Cetirizine OTC as of 2019)
Table 17. Global Pharma and Cetirizine OTC Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Pharma and Cetirizine OTC Manufacturing Sites and Area Served
Table 19. Manufacturers Pharma and Cetirizine OTC Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Pharma and Cetirizine OTC Players
Table 22. Global Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 23. Global Pharma and Cetirizine OTC Sales Share by Type (2015-2020)
Table 24. Global Pharma and Cetirizine OTC Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Pharma and Cetirizine OTC Price (K Units) by Type (2015-2020)
Table 26. Global Pharma and Cetirizine OTC Sales Share by Type (2021-2026)
Table 27. Global Pharma and Cetirizine OTC Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Pharma and Cetirizine OTC Revenue Share by Type (2021-2026)
Table 29. Global Pharma and Cetirizine OTC Price (K Units) by Type (2021-2026)
Table 30. Global Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 31. Global Pharma and Cetirizine OTC Sales Share by Application (2015-2020)
Table 32. Global Pharma and Cetirizine OTC Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Pharma and Cetirizine OTC Price (K Units) by Application (2015-2020)
Table 34. Global Pharma and Cetirizine OTC Sales (K Units) by Application (2021-2026)
Table 35. Global Pharma and Cetirizine OTC Sales Share by Application (2021-2026)
Table 36. Global Pharma and Cetirizine OTC Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Pharma and Cetirizine OTC Revenue Share by Application (2021-2026)
Table 38. Global Pharma and Cetirizine OTC Price (K Units) by Application (2021-2026)
Table 39. United States Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 40. United States Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 41. United States Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 42. United States Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 43. United States Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 44. United States Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
Table 45. Europe Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 46. Europe Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 47. Europe Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 48. Europe Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 49. Europe Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 50. Europe Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 51. China Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 52. China Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 53. China Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 54. China Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 55. China Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 56. China Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
Table 57. Japan Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 58. Japan Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 59. Japan Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 60. Japan Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 61. Japan Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 62. Japan Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
Table 69. India Pharma and Cetirizine OTC Sales (K Units) by Company (2015-2020)
Table 70. India Pharma and Cetirizine OTC Sales Market Share by Company (2015-2020)
Table 71. India Pharma and Cetirizine OTC Sales (K Units) by Type (2015-2020)
Table 72. India Pharma and Cetirizine OTC Sales Market Share by Type (2015-2020)
Table 73. India Pharma and Cetirizine OTC Sales (K Units) by Application (2015-2020)
Table 74. India Pharma and Cetirizine OTC Sales Market Share by Application (2015-2020)
Table 75. J & J Corporation Information
Table 76. J & J Description and Business Overview
Table 77. J & J Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. J & J Pharma and Cetirizine OTC Product
Table 79. J & J Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi Pharma and Cetirizine OTC Product
Table 84. Sanofi Recent Development
Table 85. Pl Developments Corporation Information
Table 86. Pl Developments Description and Business Overview
Table 87. Pl Developments Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pl Developments Pharma and Cetirizine OTC Product
Table 89. Pl Developments Recent Development
Table 90. APOTEX Corporation Information
Table 91. APOTEX Description and Business Overview
Table 92. APOTEX Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. APOTEX Pharma and Cetirizine OTC Product
Table 94. APOTEX Recent Development
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Pharma and Cetirizine OTC Product
Table 99. Teva Recent Development
Table 100. Mckesson Corporation Information
Table 101. Mckesson Description and Business Overview
Table 102. Mckesson Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Mckesson Pharma and Cetirizine OTC Product
Table 104. Mckesson Recent Development
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Perrigo Pharma and Cetirizine OTC Product
Table 109. Perrigo Recent Development
Table 110. Perrigo Corporation Information
Table 111. Perrigo Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Perrigo Description and Business Overview
Table 113. Perrigo Pharma and Cetirizine OTC Product
Table 114. Perrigo Recent Development
Table 115. CVS Pharmacy Corporation Information
Table 116. CVS Pharmacy Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. CVS Pharmacy Description and Business Overview
Table 118. CVS Pharmacy Pharma and Cetirizine OTC Product
Table 119. CVS Pharmacy Recent Development
Table 120. Major® Pharmaceuticals Corporation Information
Table 121. Major® Pharmaceuticals Description and Business Overview
Table 122. Major® Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Major® Pharmaceuticals Pharma and Cetirizine OTC Product
Table 124. Major® Pharmaceuticals Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Mylan Pharma and Cetirizine OTC Product
Table 129. Mylan Recent Development
Table 130. Amneal Corporation Information
Table 131. Amneal Description and Business Overview
Table 132. Amneal Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Amneal Pharma and Cetirizine OTC Product
Table 134. Amneal Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Novartis Pharma and Cetirizine OTC Product
Table 139. Novartis Recent Development
Table 140. Cardinal Corporation Information
Table 141. Cardinal Description and Business Overview
Table 142. Cardinal Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Cardinal Pharma and Cetirizine OTC Product
Table 144. Cardinal Recent Development
Table 145. Jubilant Life Sciences Corporation Information
Table 146. Jubilant Life Sciences Description and Business Overview
Table 147. Jubilant Life Sciences Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Jubilant Life Sciences Pharma and Cetirizine OTC Product
Table 149. Jubilant Life Sciences Recent Development
Table 150. Novel Laboratories Corporation Information
Table 151. Novel Laboratories Description and Business Overview
Table 152. Novel Laboratories Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Novel Laboratories Pharma and Cetirizine OTC Product
Table 154. Novel Laboratories Recent Development
Table 155. Medline Corporation Information
Table 156. Medline Description and Business Overview
Table 157. Medline Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Medline Pharma and Cetirizine OTC Product
Table 159. Medline Recent Development
Table 160. Macleods Corporation Information
Table 161. Macleods Description and Business Overview
Table 162. Macleods Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Macleods Pharma and Cetirizine OTC Product
Table 164. Macleods Recent Development
Table 165. Torrent Pharmaceuticals Corporation Information
Table 166. Torrent Pharmaceuticals Description and Business Overview
Table 167. Torrent Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Torrent Pharmaceuticals Pharma and Cetirizine OTC Product
Table 169. Torrent Pharmaceuticals Recent Development
Table 170. Micro Labs Corporation Information
Table 171. Micro Labs Description and Business Overview
Table 172. Micro Labs Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Micro Labs Pharma and Cetirizine OTC Product
Table 174. Micro Labs Recent Development
Table 175. Dr. Reddy's Corporation Information
Table 176. Dr. Reddy's Description and Business Overview
Table 177. Dr. Reddy's Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Dr. Reddy's Pharma and Cetirizine OTC Product
Table 179. Dr. Reddy's Recent Development
Table 180. Cipla Corporation Information
Table 181. Cipla Description and Business Overview
Table 182. Cipla Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Cipla Pharma and Cetirizine OTC Product
Table 184. Cipla Recent Development
Table 185. Aurobindo Pharma Corporation Information
Table 186. Aurobindo Pharma Description and Business Overview
Table 187. Aurobindo Pharma Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 188. Aurobindo Pharma Pharma and Cetirizine OTC Product
Table 189. Aurobindo Pharma Recent Development
Table 190. Glenmark Corporation Information
Table 191. Glenmark Description and Business Overview
Table 192. Glenmark Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 193. Glenmark Pharma and Cetirizine OTC Product
Table 194. Glenmark Recent Development
Table 195. Synthon Corporation Information
Table 196. Synthon Description and Business Overview
Table 197. Synthon Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 198. Synthon Pharma and Cetirizine OTC Product
Table 199. Synthon Recent Development
Table 200. Magno-Humphries Corporation Information
Table 201. Magno-Humphries Description and Business Overview
Table 202. Magno-Humphries Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 203. Magno-Humphries Pharma and Cetirizine OTC Product
Table 204. Magno-Humphries Recent Development
Table 205. Unique Pharmaceutical Corporation Information
Table 206. Unique Pharmaceutical Description and Business Overview
Table 207. Unique Pharmaceutical Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 208. Unique Pharmaceutical Pharma and Cetirizine OTC Product
Table 209. Unique Pharmaceutical Recent Development
Table 210. Allegiant Health Corporation Information
Table 211. Allegiant Health Description and Business Overview
Table 212. Allegiant Health Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 213. Allegiant Health Pharma and Cetirizine OTC Product
Table 214. Allegiant Health Recent Development
Table 215. Silarx Pharmaceuticals Corporation Information
Table 216. Silarx Pharmaceuticals Description and Business Overview
Table 217. Silarx Pharmaceuticals Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 218. Silarx Pharmaceuticals Pharma and Cetirizine OTC Product
Table 219. Silarx Pharmaceuticals Recent Development
Table 220. Sun Pharma Corporation Information
Table 221. Sun Pharma Description and Business Overview
Table 222. Sun Pharma Pharma and Cetirizine OTC Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 223. Sun Pharma Pharma and Cetirizine OTC Product
Table 224. Sun Pharma Recent Development
Table 225. Production Base and Market Concentration Rate of Raw Material
Table 226. Key Suppliers of Raw Materials
Table 227. Pharma and Cetirizine OTC Distributors List
Table 228. Pharma and Cetirizine OTC Customers List
Table 229. Pharma and Cetirizine OTC Market Key Trends
Table 230. Pharma and Cetirizine OTC Key Opportunities and Drivers
Table 231. Pharma and Cetirizine OTC Market Challenges
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma and Cetirizine OTC Product Picture
Figure 2. Global Pharma and Cetirizine OTC Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Pharma and Cetirizine OTC Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Drug Store Examples
Figure 9. Other Examples
Figure 10. Global Pharma and Cetirizine OTC Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Pharma and Cetirizine OTC Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Pharma and Cetirizine OTC Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Pharma and Cetirizine OTC Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Pharma and Cetirizine OTC Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Pharma and Cetirizine OTC Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Pharma and Cetirizine OTC Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Pharma and Cetirizine OTC Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Pharma and Cetirizine OTC Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Pharma and Cetirizine OTC Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Pharma and Cetirizine OTC Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Pharma and Cetirizine OTC Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Pharma and Cetirizine OTC Players Market Share by Revenue in Pharma and Cetirizine OTC 2015 & 2019
Figure 28. Pharma and Cetirizine OTC Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Pharma and Cetirizine OTC Revenue Share by Type (2015-2020)
Figure 30. Global Pharma and Cetirizine OTC Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Pharma and Cetirizine OTC Revenue Share by Application (2015-2020)
Figure 32. Global Pharma and Cetirizine OTC Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 34. United States Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 35. Europe Pharma and Cetirizine OTC Sales Market Share by Company in 2019
Figure 36. Europe Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 37. Europe Pharma and Cetirizine OTC Sales Market Share by Application in 2019
Figure 38. China Pharma and Cetirizine OTC Sales Market Share by Company in 2019
Figure 39. China Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 40. China Pharma and Cetirizine OTC Sales Market Share by Application in 2019
Figure 41. Japan Pharma and Cetirizine OTC Sales Market Share by Company in 2019
Figure 42. Japan Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 43. Japan Pharma and Cetirizine OTC Sales Market Share by Application in 2019
Figure 44. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Company in 2019
Figure 45. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 46. Southeast Asia Pharma and Cetirizine OTC Sales Market Share by Application in 2019
Figure 47. India Pharma and Cetirizine OTC Sales Market Share by Company in 2019
Figure 48. India Pharma and Cetirizine OTC Sales Market Share by Type in 2019
Figure 49. India Pharma and Cetirizine OTC Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Pharma and Cetirizine OTC
Figure 52. Manufacturing Process Analysis of Pharma and Cetirizine OTC
Figure 53. Pharma and Cetirizine OTC Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed